Last reviewed · How we verify
intravenous sufentanil
intravenous sufentanil is a Small molecule drug developed by Jun Wang. It is currently FDA-approved. Also known as: SI.
At a glance
| Generic name | intravenous sufentanil |
|---|---|
| Also known as | SI |
| Sponsor | Jun Wang |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Oliceridine Versus Sufentanil for Postoperative Nausea in Cerebellopontine Angle Surgery (NA)
- The Efficacy and Safety of Liposomal Bupivacaine for Transversus Abdominis Plane Block in Relieving Postoperative Pain After Laparoscopic Surgery (NA)
- The Efficacy and Safety of Liposomal Bupivacaine for Transversus Abdominis Plane Block in Relieving Postoperative Pain After Laparoscopic Surgery in Gynecologic Oncology (NA)
- The Efficacy and Safety of Liposomal Bupivacaine in Relieving Postoperative Pain After Laparoscopic Surgery (NA)
- Comparison of Anesthetic Techniques for Early Recovery After Ankle Arthroscopy (NA)
- The Efficacy and Safety of Liposomal Bupivacaine in Relieving Postoperative Pain After Video-assisted Thoracoscopic Surgery (NA)
- The Efficacy and Safety of Liposomal Bupivacaine in Relieving Postoperative Pain After Hemorrhoid Surgery (NA)
- A Comparison of Remimazolam Besylate and Propofol Sedation in Patients Undergoing Colonoscopic Polypectomy (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- intravenous sufentanil CI brief — competitive landscape report
- intravenous sufentanil updates RSS · CI watch RSS
- Jun Wang portfolio CI
Frequently asked questions about intravenous sufentanil
What is intravenous sufentanil?
intravenous sufentanil is a Small molecule drug developed by Jun Wang.
Who makes intravenous sufentanil?
intravenous sufentanil is developed and marketed by Jun Wang (see full Jun Wang pipeline at /company/jun-wang).
Is intravenous sufentanil also known as anything else?
intravenous sufentanil is also known as SI.
What development phase is intravenous sufentanil in?
intravenous sufentanil is FDA-approved (marketed).
Related
- Manufacturer: Jun Wang — full pipeline
- Also known as: SI
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing